Institutional Review Boards
- administrative body ensuring human subjects protected in research * Often affiliated with university or hospitals * Review ethics protocols that include * How study will advance existing research * Who will be recruited- ages (especially If they’re minors), gender, race, sexuality * Ensure you engage appropriate populations * Making sure you protect vulnerable populations * All activities participants are asked to do and their methods * Interview, focus group, clinical trials, etc. * Consent process & compensation * Verbal vs written consent * What is in consent form? * Is compensation coercive? * Other aspects of a project * Timeline? * Done in phases? * Personnel? * Certification to work w/ human subjects * Usually there’s a template for this
- History of IRBs * Arose after violations of human rights in research (WWII Nazi & Japanese research) * 1950s-60s- early emergence * 1971- Stanford prison experiment * 1972- public revelation of Tuskegee syphilis experiment * 1979- Belmont report * Established principles of respect for autonomy, beneficence, justice in research * Common rule 1981- formal guidelines for IRBs
- Look different in different places * Ex- low risk social science research * May not be subject to IRB review in some European countries because you’re likely just talking to people * In US- still needs to be reviewed if you’re interviewing people to look for general trends
- Review all kinds of research and can specialize in some research * Hospital IRBs- clinical trials/studies * Social-behavioral IRBs- tends to review empirical social science & education research * Private IRBs- for-profit IRBs that companies can hire to review their research
- Characteristics * At least 5 members of diverse backgrounds * At least 1 scientist/researcher * At least 1 community member that’s not staff, student, or researcher in the university * Can be paid/unpaid * Protect human subjects’ interests * Can be held liable for harm occurring to participants * Reason being that they did not thoroughly review protocol and account for potential risks to participants * Participants need to be fully aware of risks and IRB needs to carefully review protocol
- Completes these tasks: * Ensures study personnel have necessary certifications * Initial review of ethics protocols for study * Work with researchers to make any adjustments * Review modifications to initial protocol as study expands/changes * In-depth audits, annual review of select protocols as needed * Can access confidential records of project for this
- Need IRB approval to start human research * Most cases- IRBs work with researchers to adjust study design to ensure participants be protected instead of outright denying researchers ability to begin their study * Can also outright approve/deny
- Follow (rev. 2018) * Sets requirements for * IRB membership * Consent process * Types of ethics protocol reviews * Vulnerable populations * Prisoners (do not necessarily have autonomy) * children (mostly bc of extra documentation/paperwork) * students (possible coercion to participate, especially if they’re students @ the university where research is happening) * pregnant individuals * Populations that may be considered vulnerable but technically aren’t in some cases * Elderly (not vulnerable if they have clarity of mind) * Mental illness/personality disorders (not vulnerable if they’re stable on medication) * But IRB will ask how you ensure they have DMC and capacity to give consent * Other important parts * Must inform participants if data used for something else other than study * Must inform participants if their biospecimens will be used for purposes where there is commercial profit * Educational research is exempt from review if data is being gathered on educational practices already in use * You can’t determine whether it’s human subject research or not * Consent forms must be made publicly available online for some federal-funded clinical trials
- IRBs interpret common rule guidelines * Different IRBs can make diff decisions
- 3 types of IRB review - IRB decides which one * Full review- all members of committee come together and read protocol and decide any modifications * Usually for studies with potential risk * Example- clinical trials for new medication * Expedited- only review by 1 member of the IRB * For studies with minimal risk but still considered human subjects research * Member chosen based on different characteristics * Example- study interviewing patients about experiences accessing mental healthcare * Exempt- ethics protocol is submitted but not reviewed by IRB bc they deem it not to be human subject research * Example- studying how much information students retain after class * Time length depends on IRB but generally takes a while
- Types of research not reviewed by IRB * Not direct work with human subjects * Animal research- reviewed by Institutional Animal Care and Use Committee * Research using existing de-identified data sets * Using deidentified human specimens * Educational research
- Consider following in ethics protocols review * Confidentiality * Data management & security * Compensation of participants * Special accommodations for vulnerable populations * Risks and benefits * Placebos in clinical research
- Confidentiality is the main concern * Common suggestions * Never publicly name a research participant * But they can talk about * Data distinguished with participant ID # instead of their name * In presentation & published reports- participants given pseudonyms where appropriate * Certain details not provided if they’d result in identification of participants
- Data management is another important concern * Electronic storage needs to be encrypted * Physical forms needed to be stored in locked files in locked office * Only people designated as researchers and members of IRB can access * Store data in separate location than data identifying ID# and their name
- Compensation * Will they paid? * How much will they paid? * Is compensation coercive? * This depends on who’s compensated * Not compensating also unethical * Medical care provided for free viewed as “benefit” not as compensation
- Vulnerable populations special considerations * Pregnant people- Is the risk to the fetus mitigated? What happens if participant becomes pregnant? * Children- Can they give assent? Should parent/guardian consent be waived? * Prisoners- Do they have ability to freely decide? Autonomy is impacted * Students- Ensure grades and relationships to university will not be impacted
- Risk and benefits assessment * Risk should be minimized and/or made relative to benefits * Placebos * Should only be used when patients not put at undue risk by not receiving active treatment
\